Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Neuroendocrinology|August 12, 2016
The Effect of the Exon-3-Deleted Growth Hormone Receptor on Pegvisomant-Treated Acromegaly: A Systematic Review and Meta-AnalysisSanne E Franck, Linda Broer, Aart Jan van der Lely, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 23, 2009
Increased programmed death-1 molecule expression in cytomegalovirus disease and acute graft-versus-host disease after allogeneic hematopoietic cell transplantationGhislaine M Gallez-Hawkins, Lia Thao, Joycelynne Palmer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 21, 2011
Expression of activating KIR2DS2 and KIR2DS4 genes after hematopoietic cell transplantation: relevance to cytomegalovirus infectionGhislaine M Gallez-Hawkins, Anne E Franck, Xiuli Li, et al.
The Journal of Clinical Endocrinology and Metabolism|October 23, 2018
Pasireotide Responsiveness in Acromegaly Is Mainly Driven by Somatostatin Receptor Subtype 2 ExpressionAmmar Muhammad, Eva C Coopmans, Federico Gatto, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 9, 2005
Cytomegalovirus immune reconstitution occurs in recipients of allogeneic hematopoietic cell transplants irrespective of detectable cytomegalovirus infectionGhislaine Gallez-Hawkins, Lia Thao, Simon F Lacey, et al.
Neuroendocrinology|July 26, 2016
Somatostatin Receptor Expression in GH-Secreting Pituitary Adenomas Treated with Long-Acting Somatostatin Analogues in Combination with PegvisomantSanne E Franck, Federico Gatto, Aart Jan van der Lely, et al.
The Journal of Clinical Endocrinology and Metabolism|March 22, 2017
In Vitro Head-to-Head Comparison Between Octreotide and Pasireotide in GH-Secreting Pituitary AdenomasFederico Gatto, Richard A Feelders, Sanne E Franck, et al.
Physical Review Letters|September 27, 2014
Mechanism of edge localized mode mitigation by resonant magnetic perturbationsM Bécoulet, F Orain, G T A Huijsmans, et al.
European Journal of Endocrinology|July 27, 2022
Digital quantification of somatostatin receptor subtype 2a immunostaining: a validation studyClaudia Campana, Peter M van Koetsveld, Richard A Feelders, et al.
The Journal of Clinical Endocrinology and Metabolism|June 18, 2014
Long-term efficacy and safety of pegvisomant in combination with long-acting somatostatin analogs in acromegalyS J C M M Neggers, S E Franck, F W M de Rooij, et al.
Pageof 5